Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-Cell Viability Assay
Authors:
- 1 January 1993
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 28 (1) , 21-27
Abstract
Preliminary clinical data show promising activity regarding the combination of paclitaxel (TaxolTM) (TAX) and doxorubicin (AdriamycinTM) (ADR) in the treatment of breast cancer. This combination needs both further preclinical and clinical investigations to better understand the drug interaction, and to optimize the dose and schedule of these drugs. This study was done to evaluate the combination effect of TAX and ADR in three human breast cancer cell lines. The ATP-Cell-Viability Assay was used to evaluate the chemosensitivity profiles and to obtain dose response curves. For quantitation of synergism and antagonism the median-effect principle was applied and the corresponding combination index values were calculated. Drug synergism/antagonism was shown to be dose-related; synergism was enhanced at higher fractions affected. From this preclinical data, we have concluded that TAX-ADR is highly effective and partly synergisticin vitro. In spite of severe initial toxicities in early clinical trials in metastatic breast cancer patients, further clinical studies appear to be justified in order to define a tolerable dosage.Keywords
This publication has 27 references indexed in Scilit:
- The use of ATP bioluminescence assay and flow cytometry in predicting radiosensitivity of uterine cancer cell lines: Correlation of radiotoxicity and cell cycle kineticsGynecologic Oncology, 1992
- Overview of new treatments for breast cancerBreast Cancer Research and Treatment, 1992
- Rationale of Combining Radiation and Interferon for the Treatment of Cervical CancerOncology, 1992
- Comparative evaluation of single and combination chemotherapy in uterine cancer cell linesGynecologic Oncology, 1991
- The effects of provera on chemotherapy of uterine cancer cell linesGynecologic Oncology, 1991
- A novel in vitro chemosensitivity test using materials collected by endoscopic biopsyAnti-Cancer Drugs, 1991
- Comparative chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescenceGynecologic Oncology, 1990
- Application of an ATP-bioluminescence assay in human tumor chemosensitivity testingGynecologic Oncology, 1988
- Comparison of the chemosensitivity of human neoplastic tissues between succinate dehydrogenase inhibition test and ATP assayClinica Chimica Acta, 1987
- The Use of Bioluminescence to Evaluate the Influence of Chemotherapeutic Drugs on ATP-Levels of Malignant Cell LinesClinical Chemistry and Laboratory Medicine (CCLM), 1986